BMIYX
Price
$7.10
Change
-$0.08 (-1.11%)
Updated
Feb 21 closing price
Net Assets
182.01M
RMEBX
Price
$57.54
Change
-$0.62 (-1.07%)
Updated
Feb 21 closing price
Net Assets
105.48B
Ad is loading...

BMIYX vs RMEBX

Header iconBMIYX vs RMEBX Comparison
Open Charts BMIYX vs RMEBXBanner chart's image
BNY Mellon Income Stock Y
Price$7.10
Change-$0.08 (-1.11%)
VolumeN/A
Net Assets182.01M
American Funds American Mutual R2E
Price$57.54
Change-$0.62 (-1.07%)
VolumeN/A
Net Assets105.48B
BMIYX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BMIYX vs. RMEBX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMIYX is a StrongBuy and RMEBX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 105B vs. BMIYX (182M). BMIYX pays higher dividends than RMEBX: BMIYX (1.92) vs RMEBX (1.54). BMIYX was incepted earlier than RMEBX: BMIYX (9 years) vs RMEBX (10 years). BMIYX is a more actively managed with annual turnover of: 83.54 vs. RMEBX (25.00). RMEBX has a lower initial minimum investment than BMIYX: RMEBX (250) vs BMIYX (1000000). RMEBX annual gain was more profitable for investors over the last year : 10.88 vs. BMIYX (-2.33). RMEBX return over 5 years is better than : 40.75 vs. BMIYX (-11.59).
BMIYXRMEBXBMIYX / RMEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years10 years-
Gain YTD4.7994.809100%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets182M105B0%
Annual Yield % from dividends1.921.54125%
Returns for 1 year-2.3310.88-21%
Returns for 3 years-19.2319.18-100%
Returns for 5 years-11.5940.75-28%
Returns for 10 yearsN/A63.29-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLX157.254.18
+2.73%
Clorox Company
NEOG10.04N/A
N/A
Neogen Corp
NRXS2.31-0.02
-0.85%
Neuraxis
COGT8.00-0.09
-1.11%
Cogent Biosciences
LRMR3.19-0.08
-2.45%
Larimar Therapeutics